As a risk factor of mortality in patients with sepsis in the intensive care unit and long term follow-up: Trombocytopenia Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Does plasma NGAL help for prediction of acute kidney injury in sepsis patients?: A systematic review and meta-analysis Source: International Congress 2015 – Acute critical care: novelties in critical care Year: 2015
Characterization and identification of novel serum miRNAs in sepsis patients with different outcomes Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
Natriuretic peptide as a prognostic biomarker in septic shock in respiratory intensive care Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Model of diagnosis scoring, clinical and molecular profile of invasive pulmonary aspergillosis (IPA) in ICU patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015
Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
ICU and twelve-month mortality of patients with acute respiratory failure admitted to the ICU: What is the role of comorbidities? Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016
The impact of bundle care on medical expenses reduction in critically-ill patients with blood stream infection Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013
The dynamic changes of amino acid expression profiles in patients with sepsis Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Outcome and prognostic factors of patients with lung cancer admitted to intensive care unit Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning Year: 2015
Blood urea nitrogen/ albumin ratio: Is it a new predictor for prognosis of community-acquired pneumonia? Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Pneumonia in neutropenic patients with haematologic malignancies and disorders: Frequency and predictors of ICU admission at a tertiary care hospital in Karachi, Pakistan Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016
Postoperative pulmonary complications are associated to higher ICU cost Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
The relationship between delayed anti-TB treatment and hospital mortality in critically ill patients Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Acute critical care: news from the ICU Year: 2015
Plasma pro-endothelin-1 as marker of severe lung injury in very preterm infants Source: International Congress 2014 – Lung disease in neonates and beyond Year: 2014
Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017